We previously demonstrated that HER2/neu-driven mammary carcinogenesis can be prevented by an interleukin-12 (IL-12)-adjuvanted allogeneic HER2/neu-expressing cell vaccine. Since IL-12 can induce the release of interleukin-15 (IL-15), in the present study we investigated the role played by IL-15 in HER2/neu driven mammary carcinogenesis and in its immunoprevention.
Croci, S., Nanni, P., Palladini, A., Nicoletti, G., Grosso, V., Benegiamo, G., et al. (2015). Interleukin-15 is required for immunosurveillance and immunoprevention of HER2/neu-driven mammary carcinogenesis. BREAST CANCER RESEARCH, 17, 1-13 [10.1186/s13058-015-0588-x].
Interleukin-15 is required for immunosurveillance and immunoprevention of HER2/neu-driven mammary carcinogenesis
CROCI, STEFANIA;NANNI, PATRIZIA;PALLADINI, ARIANNA;GROSSO, VALENTINA;IANZANO, MARIANNA LUCIA;DALL'ORA, MASSIMILIANO;DE GIOVANNI, CARLA
;LOLLINI, PIER LUIGI
2015
Abstract
We previously demonstrated that HER2/neu-driven mammary carcinogenesis can be prevented by an interleukin-12 (IL-12)-adjuvanted allogeneic HER2/neu-expressing cell vaccine. Since IL-12 can induce the release of interleukin-15 (IL-15), in the present study we investigated the role played by IL-15 in HER2/neu driven mammary carcinogenesis and in its immunoprevention.| File | Dimensione | Formato | |
|---|---|---|---|
|
IL-15 Breast Cancer Res.pdf
accesso aperto
Descrizione: Research article
Tipo:
Versione (PDF) editoriale / Version Of Record
Licenza:
Licenza per Accesso Aperto. Creative Commons Attribuzione (CCBY)
Dimensione
1.37 MB
Formato
Adobe PDF
|
1.37 MB | Adobe PDF | Visualizza/Apri |
|
Additional files.zip
accesso aperto
Descrizione: Additional files
Tipo:
File Supplementare
Licenza:
Licenza per accesso libero gratuito
Dimensione
123.08 kB
Formato
Zip File
|
123.08 kB | Zip File | Visualizza/Apri |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
